Glucocorticoid binding proteins in myeloblasts of acute myelogenous leukemia

Marc E Lippman, Seymour Perry, E. Brad Thompson

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The myeloblasts of 16 patients with untreated acute myelogenous leukemia were examined for specific glucocorticoid binding proteins. In only 3 of the 16 patients were such high affinity receptors found. The presence of glucocorticoid binding protein activity was positively correlated with inhibition of macromolecular synthesis of myeloblasts in vitro whereas absence of binding protein activity was associated with lack of glucocorticoid inhibition of the cells. Since glucocorticoids appear efficacious in only a small fraction of cases of acute myelogenous leukemia, determination of glucocorticoid binding protein activity may provide assistance in planning chemotherapeutic regimens.

Original languageEnglish
Pages (from-to)224-227
Number of pages4
JournalThe American Journal of Medicine
Volume59
Issue number2
DOIs
StatePublished - Jan 1 1975
Externally publishedYes

Fingerprint

Granulocyte Precursor Cells
Acute Myeloid Leukemia
Glucocorticoids
Carrier Proteins

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Glucocorticoid binding proteins in myeloblasts of acute myelogenous leukemia. / Lippman, Marc E; Perry, Seymour; Thompson, E. Brad.

In: The American Journal of Medicine, Vol. 59, No. 2, 01.01.1975, p. 224-227.

Research output: Contribution to journalArticle

Lippman, Marc E ; Perry, Seymour ; Thompson, E. Brad. / Glucocorticoid binding proteins in myeloblasts of acute myelogenous leukemia. In: The American Journal of Medicine. 1975 ; Vol. 59, No. 2. pp. 224-227.
@article{3a8c8a65425f4f85a29e770ea215ceea,
title = "Glucocorticoid binding proteins in myeloblasts of acute myelogenous leukemia",
abstract = "The myeloblasts of 16 patients with untreated acute myelogenous leukemia were examined for specific glucocorticoid binding proteins. In only 3 of the 16 patients were such high affinity receptors found. The presence of glucocorticoid binding protein activity was positively correlated with inhibition of macromolecular synthesis of myeloblasts in vitro whereas absence of binding protein activity was associated with lack of glucocorticoid inhibition of the cells. Since glucocorticoids appear efficacious in only a small fraction of cases of acute myelogenous leukemia, determination of glucocorticoid binding protein activity may provide assistance in planning chemotherapeutic regimens.",
author = "Lippman, {Marc E} and Seymour Perry and Thompson, {E. Brad}",
year = "1975",
month = "1",
day = "1",
doi = "10.1016/0002-9343(75)90357-5",
language = "English",
volume = "59",
pages = "224--227",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Glucocorticoid binding proteins in myeloblasts of acute myelogenous leukemia

AU - Lippman, Marc E

AU - Perry, Seymour

AU - Thompson, E. Brad

PY - 1975/1/1

Y1 - 1975/1/1

N2 - The myeloblasts of 16 patients with untreated acute myelogenous leukemia were examined for specific glucocorticoid binding proteins. In only 3 of the 16 patients were such high affinity receptors found. The presence of glucocorticoid binding protein activity was positively correlated with inhibition of macromolecular synthesis of myeloblasts in vitro whereas absence of binding protein activity was associated with lack of glucocorticoid inhibition of the cells. Since glucocorticoids appear efficacious in only a small fraction of cases of acute myelogenous leukemia, determination of glucocorticoid binding protein activity may provide assistance in planning chemotherapeutic regimens.

AB - The myeloblasts of 16 patients with untreated acute myelogenous leukemia were examined for specific glucocorticoid binding proteins. In only 3 of the 16 patients were such high affinity receptors found. The presence of glucocorticoid binding protein activity was positively correlated with inhibition of macromolecular synthesis of myeloblasts in vitro whereas absence of binding protein activity was associated with lack of glucocorticoid inhibition of the cells. Since glucocorticoids appear efficacious in only a small fraction of cases of acute myelogenous leukemia, determination of glucocorticoid binding protein activity may provide assistance in planning chemotherapeutic regimens.

UR - http://www.scopus.com/inward/record.url?scp=0016593213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016593213&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(75)90357-5

DO - 10.1016/0002-9343(75)90357-5

M3 - Article

C2 - 1057376

AN - SCOPUS:0016593213

VL - 59

SP - 224

EP - 227

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 2

ER -